Sucralfate Suspension
Product Images NDC 82182-106

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 82182-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pacific Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sucralfate Oral Suspension Contains Sucralfate And Sucralfate Is An α-d-glucopyranoside, β-d- Fructofuranosyl-, Octakis-(hydrogen Sulfate), Aluminum Complex. (Sucralfate Oral Suspension 01)

Chemical structure diagram of sucralfate showing polysaccharide rings with attached sulfate and aluminum hydroxide groups, accompanied by a chemical formula indicating variable hydroxide and water components.*

FDA Label Image

Principal Display Panelndc 82182-106-14 20079114sycralfate Oral Suspension1g/10mlone 420ml Bottleshake Well Before Usingavoid Freezingrx Only (Sucralfate Oral Suspension 02)

Label for Sucralfate Oral Suspension 1 g/10 mL, in a 420 mL bottle by Pacific Pharma, Inc. The label instructs users to shake well before using and avoid freezing. It includes dosage instructions, warnings, storage conditions, and distributor information for Pacific Pharma, North Chicago, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.